248 related articles for article (PubMed ID: 16526552)
21. Effect of the unstirred water layer on permeability enhancement by hydrophilic cyclodextrins.
Brewster ME; Noppe M; Peeters J; Loftsson T
Int J Pharm; 2007 Sep; 342(1-2):250-3. PubMed ID: 17560057
[TBL] [Abstract][Full Text] [Related]
22. Solubility and permeability of steroids in water in the presence of potassium halides.
Messner M; Loftsson T
Pharmazie; 2010 Feb; 65(2):83-5. PubMed ID: 20225648
[TBL] [Abstract][Full Text] [Related]
23. Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing.
Másson M; Loftsson T; Másson G; Stefánsson E
J Control Release; 1999 May; 59(1):107-18. PubMed ID: 10210727
[TBL] [Abstract][Full Text] [Related]
24. Cyclodextrins as solubilizers: formation of complex aggregates.
Jansook P; Kurkov SV; Loftsson T
J Pharm Sci; 2010 Feb; 99(2):719-29. PubMed ID: 19670293
[TBL] [Abstract][Full Text] [Related]
25. Permeability through DOPC/dodecane membranes: measurement and LFER modelling.
Huque FT; Box K; Platts JA; Comer J
Eur J Pharm Sci; 2004 Nov; 23(3):223-32. PubMed ID: 15489123
[TBL] [Abstract][Full Text] [Related]
26. Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery.
McCormack B; Gregoriadis G
J Drug Target; 1994; 2(5):449-54. PubMed ID: 7704490
[TBL] [Abstract][Full Text] [Related]
27. Modulation of release rate and barrier transport of Diclofenac incorporated in hydrophilic matrices: role of cyclodextrins and implications in oral drug delivery.
Miro A; Rondinone A; Nappi A; Ungaro F; Quaglia F; La Rotonda MI
Eur J Pharm Biopharm; 2009 May; 72(1):76-82. PubMed ID: 19135532
[TBL] [Abstract][Full Text] [Related]
28. Effect of alpha-cyclodextrin on drug distribution studied by electrochemistry at interfaces between immiscible electrolyte solutions.
Deryabina MA; Hansen SH; Østergaard J; Jensen H
J Phys Chem B; 2009 May; 113(20):7263-9. PubMed ID: 19397256
[TBL] [Abstract][Full Text] [Related]
29. PAMPA--a drug absorption in vitro model 8. Apparent filter porosity and the unstirred water layer.
Nielsen PE; Avdeef A
Eur J Pharm Sci; 2004 May; 22(1):33-41. PubMed ID: 15113581
[TBL] [Abstract][Full Text] [Related]
30. Liposomes incorporating cyclodextrin-drug inclusion complexes: Current state of knowledge.
Gharib R; Greige-Gerges H; Fourmentin S; Charcosset C; Auezova L
Carbohydr Polym; 2015 Sep; 129():175-86. PubMed ID: 26050903
[TBL] [Abstract][Full Text] [Related]
31. On the large error introduced in the estimate of the density of membrane pores from permeability measurements when diffusion in "unstirred layer" within the cells is disregarded.
Ling GN
Physiol Chem Phys Med NMR; 1987; 19(3):199-207. PubMed ID: 3441521
[TBL] [Abstract][Full Text] [Related]
32. Absorption-excipient-pH classification gradient maps: sparingly soluble drugs and the pH partition hypothesis.
Avdeef A; Kansy M; Bendels S; Tsinman K
Eur J Pharm Sci; 2008 Jan; 33(1):29-41. PubMed ID: 17983735
[TBL] [Abstract][Full Text] [Related]
33. Estimation of effective intestinal membrane permeability considering bile micelle solubilisation.
Sugano K
Int J Pharm; 2009 Feb; 368(1-2):116-22. PubMed ID: 18992315
[TBL] [Abstract][Full Text] [Related]
34. Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability.
Flaten GE; Skar M; Luthman K; Brandl M
Eur J Pharm Sci; 2007 Mar; 30(3-4):324-32. PubMed ID: 17204409
[TBL] [Abstract][Full Text] [Related]
35. The unstirrable water layer is unstirrable because it does not exist.
Scherrer RA
Chem Biodivers; 2009 Nov; 6(11):1917-22. PubMed ID: 19937829
[TBL] [Abstract][Full Text] [Related]
36. Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics.
Piel G; Piette M; Barillaro V; Castagne D; Evrard B; Delattre L
Int J Pharm; 2006 Apr; 312(1-2):75-82. PubMed ID: 16455215
[TBL] [Abstract][Full Text] [Related]
37. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
Loftsson T; Sigurdsson HH; Konrádsdóttir F; Gísladóttir S; Jansook P; Stefánsson E
Pharmazie; 2008 Mar; 63(3):171-9. PubMed ID: 18444504
[TBL] [Abstract][Full Text] [Related]
38. Influence of membrane-solvent-solute interactions on solute permeation in model membranes.
Dias M; Hadgraft J; Lane ME
Int J Pharm; 2007 May; 336(1):108-14. PubMed ID: 17204382
[TBL] [Abstract][Full Text] [Related]
39. Transport of a lipophilic ionizable permeant (capric acid) across a lipophilic membrane (silicone polymer membrane) from aqueous buffered solutions in the presence of hydroxypropyl-β-cyclodextrin.
Hymas RV; Ho NF; Higuchi WI
J Pharm Sci; 2012 Jul; 101(7):2340-52. PubMed ID: 22544457
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins.
Hamada H; Ishihara K; Masuoka N; Mikuni K; Nakajima N
J Biosci Bioeng; 2006 Oct; 102(4):369-71. PubMed ID: 17116587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
